Aseptic liquid medium for antibody pharmaceuticals for regenerative medicine
Liquid medium compliant with GMP, supporting cell culture.
In the field of regenerative medicine, the quality and safety of cells are the most important issues. The culture media used for cell culture must promote cell proliferation and provide a stable supply of high-quality cells. Our products are manufactured in compliance with GMP standards and strongly support cell culture in regenerative medicine. 【Application Scenarios】 - Cell therapy - Biopharmaceutical development - Research and development 【Benefits of Implementation】 - Stabilization of cell culture - Supply of high-quality cells - Increased efficiency in research and development
basic information
**Features** - Manufacturing environment compliant with GMP - Production line capable of handling small quantities and a variety of products - Extensive use of single-use equipment - Strict raw material management - Containers compatible with bottles and single-use bags **Our Strengths** We are a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Ltd. By combining Ajinomoto's high-quality amino acid-based culture media raw materials and formulation development technology with Koji Bio's advanced liquid culture media production technology, we provide high-quality liquid culture media.
Price information
Please contact us separately.
Delivery Time
Applications/Examples of results
For more details, please download the PDF or contact us.
catalog(3)
Download All CatalogsRecommended products
Distributors
In June 2018, we established Ajinomoto Koji Bio Co., Inc. as a joint venture between Ajinomoto Co., Inc. and Koji Bio Co., Inc. We combined Ajinomoto Co., Inc.'s high-quality amino acids as the foundation for culture media raw materials and their formulation development technology with Koji Bio Co., Inc.'s advanced liquid culture media production technology to launch a contract manufacturing company for clinical culture media necessary for regenerative medicine. Currently, we are engaged in contract manufacturing of liquid media and buffers for customers in cell therapy and biopharmaceuticals, enhancing our significance in the industry.



















